|
ZNF292 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.6024005173042E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11230002985963E-09 |
| Normal-vs-Stage2 |
4.13400003118625E-09 |
| Normal-vs-Stage3 |
4.48780013151406E-10 |
| Normal-vs-Stage4 |
7.43950456794096E-11 |
| Stage1-vs-Stage2 |
2.998400E-01 |
| Stage1-vs-Stage3 |
4.382000E-01 |
| Stage1-vs-Stage4 |
9.356000E-02 |
| Stage2-vs-Stage3 |
6.604000E-01 |
| Stage2-vs-Stage4 |
7.896000E-01 |
| Stage3-vs-Stage4 |
4.301000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.16449977333377E-10 |
| Normal-vs-AfricanAmerican |
4.997500E-04 |
| Normal-vs-Asian |
5.97539995261798E-09 |
| Caucasian-vs-AfricanAmerican |
1.996760E-01 |
| Caucasian-vs-Asian |
8.284400E-01 |
| AfricanAmerican-vs-Asian |
1.974790E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.43999947918883E-10 |
| Normal-vs-Female |
3.28959970374854E-10 |
| Male-vs-Female |
8.613800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.67879998580878E-09 |
| Normal-vs-Age(41-60Yrs) |
2.48089992993528E-10 |
| Normal-vs-Age(61-80Yrs) |
1.74000036601285E-10 |
| Normal-vs-Age(81-100Yrs) |
4.399700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.379600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.443370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.415400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.367200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.238200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.187000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.929600E-01 |
| Classical-VS-Follicular |
4.176500E-03 |
| Classical-VS-Other |
2.936000E-01 |
| Classical-VS-Normal |
1.57539999934286E-08 |
| Tall-VS-Follicular |
3.589400E-01 |
| Tall-VS-Other |
5.285400E-01 |
| Tall-VS-Normal |
6.25129999987095E-08 |
| Follicular-VS-Other |
9.389000E-01 |
| Follicular-VS-Normal |
6.24009732774766E-11 |
| Other-VS-Normal |
2.136000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.87010423708034E-11 |
| Normal-vs-N1 |
4.85800000227243E-09 |
| N0-vs-N1 |
7.183600E-01 |
|
|
